The Faculty of Sexual & Reproductive Healthcare (FSRH) Clinical Effectiveness Unit (CEU) has recently published an updated intrauterine device (IUD) guideline, incorporating new evidence-based recommendations alongside refreshed established guidance.
IUDs are effective and popular long-acting reversible contraception (LARC) used by approximately 159 million users worldwide
With the addition of Benilexa® to the market in 2021, there are now three 52 mg levonorgestrel IUDs (LNG-IUDs) available in the UK. While the licensed durations and indications of use differ between the 52 mg LNG-IUDs, the FSRH Guideline Development Group advocate that the similarity between the devices and levonorgestrel (LNG) release rates is sufficient to extrapolate evidence from one device to another (
Although Mirena® is the only LNG-IUD licensed for endometrial protection…